About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Updates on CAR-T in Multiple Myeloma
Updates on CAR-T in Multiple Myeloma
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
Summary of the MAMMOTH Trial in R/R Myeloma
By
Saurabh Chhabra
491 views
December 9, 2022
0 Comments
Login to view comments.
Click here to Login
Updates on CAR-T in Multiple Myeloma
06:12
Maximilian Merz
Patient Selection for Ciltacabtagene Autoleucel Therapy in R/R MM
11:43
UCSF School of Medicine
CARTITUDE-1: 2 Years Post-LPI Update on the Phase 1b/2 Study of Cilt…
Feat.
T. Martin
15:29
SOHO Brazil 2022
SOHO Brazil 2022 on CAR-T in Refractory MM: When Is the Precise Mome…
Feat.
M. Bishop,
P. Scheinberg
21:16
UChicago Medicine
Myeloma 2022: Challenges and Path Forward
Feat.
A. Jakubowiak
04:08
GRACE
CAR T-Cell Therapy Side Effects for Blood Cancers
Feat.
A. Goodman
21:38
Rahul Banerjee
CAR-T Therapy in Myeloma: What's Here and What's Coming So…
12:11
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Pro C…
Feat.
T. Martin
14:22
SOHO 2022 Tenth Annual Meeting
SOHO 2022: CAR T-Cell in MM - When To Use Now, Where Are We Going?
Feat.
N. S. Raje
19:05
UChicago Medicine
Identifying and Managing Major Toxicities of CAR-T Therapy in Multip…
Feat.
S. Kosuri
05:32
Enrique Ocio
Triple Refractory MM Patients: Learnings From the MAMMOTH and the Lo…
08:13
Shaji Kumar
CAR-T in MM: Benefits of a Treatment-Free Interval
06:58
Saurabh Chhabra
Summary of the MAMMOTH Trial in R/R Myeloma
14:41
Zhubin Gahvari
MAMMOTH Trial: Myeloma Outcomes Post Anti-CD38 MoAbs
05:05
ASH 2022 Conference Coverage
ASH 2022 Outcomes of Penta-Refractory MM Patients Based on Access to…
Feat.
S. Atrash
14:03
ASH 2022 Conference Coverage
ASH 2022 Neurotoxicity With Motor Symptoms After BCMA-Directed CAR-T…
Feat.
S. Parekh
31:51
Indy Hematology Review
Treating Multiple Myeloma: The Cure Is Within Reach - Goals of Curre…
Feat.
K. Anderson
